Video

AHA 2021 Scientific Sessions Preview with Manesh Patel, MD

Manesh Patel, MD, program committee chair of the AHA 2021 Scientific Sessions, discusses this year's conference, previews the late-breaking sessions, and reflects on his experience as chair.

The American Heart Association (AHA) Annual Scientific Sessions is an event showcasing the latest data in cardiology and, by extension, the mission of the organization, which is emphasized in this year’s theme: One World. Together for Science.

Planned for November 13-15, this year’s conference will be conducted through a unique hybrid format. While the AHA had planned and then pivoted away from an in-person meeting out of caution, some of those involved will take part in live broadcasts throughout the weekend sessions and on Monday. With 300 on-demand sessions, 7 sessions dedicated to late-breaking science, and thousands of individual abstracts, the conference tackles a plethora of topics within cardiovascular medicine, but also in areas not typically under the purview of a cardiologist, including COVID-19.

To learn more about the forthcoming data, the theme, and the experience of putting together AHA 2021, Practical Cardiology reached out to Manesh Patel, MD, chief of cardiology and clinical pharmacology at Duke University School of Medicine and AHA 2021 program committee chair, for his perspective.

Related Videos
The APAC Recap: Cardiomyopathy at CAPP Live 2024 with Greg Duck, PA-C | Image Credit: APAC
The APAC Recap: Peripheral Artery Disease at CAPP Live 2024 with Bob Ross, PA-C | Image Credit: APAC
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.